Comprehensive feature selection for classifying the treatment outcome of high-intensity ultrasound therapy in uterine fibroids
Authors:
Preprint
Abstract
The study aim was to utilise multiple feature selection methods in order to select the most important parameters from clinical patient data for high-intensity focused ultrasound (HIFU) treatment outcome classification in uterine fibroids. The study was retrospective using patient data from 66 HIFU treatments with 89 uterine fibroids. A total of 39 features were extracted from the patient data and 14 different filter-based feature selection methods were used to select the most informative features. The selected features were then used in a support vector classification (SVC) model to evaluate the performance of these parameters in predicting HIFU therapy outcome. The therapy outcome was defined as non-perfused volume (NPV) ratio in three classes: 80%. The ten most highly ranked features in order were: fibroid diameter, subcutaneous fat thickness, fibroid volume, fibroid distance, Funaki type I, fundus location, gravidity, Funaki type III, submucosal fibroid type and urinary symptoms. The maximum F1-micro classification score was 0.63 using the top ten features from Mutual Information Maximisation (MIM) and Joint Mutual Information (JMI) feature selection methods. Classification performance of HIFU therapy outcome prediction in uterine fibroids is highly dependent on the chosen feature set which should be determined prior using different classifiers.Keywords
All Related Versions
- Version 1, 2019-09-29, ArXiv
- Published version: Scientific Reports, 9 (1), 1.
This publication has 20 references indexed in Scilit:
- Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiersMedical Physics, 2018
- Magnetic Resonance Imaging Parameters in Predicting the Treatment Outcome of High-intensity Focused Ultrasound Ablation of Uterine Fibroids With an Immediate Nonperfused Volume Ratio of at Least 90%Academic Radiology, 2018
- The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroidsAbdominal Radiology, 2017
- The role of T1 perfusion-based classification in magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroidsEuropean Radiology, 2017
- Williams Textbook of Endocrinology2016
- MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centreEuropean Radiology, 2014
- Clinical outcomes of magnetic resonance‐guided focused ultrasound surgery for uterine myomas: 24‐month follow‐upUltrasound in Obstetrics & Gynecology, 2009
- Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance imagesAmerican Journal of Obstetrics and Gynecology, 2007
- Magnetic resonance guided focused ultrasound surgery of uterine fibroids—The tissue effects of GnRH agonist pre-treatmentEuropean Journal of Radiology, 2006
- Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroidsFertility and Sterility, 2006